You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

ORIGINAL RESEARCH article

Front. Cardiovasc. Med.

Sec. Cardiovascular Surgery

Impact of Sarcopenia on Ventricular Remodelling Following Coronary Artery Bypass Grafting in Elderly Patients with Coronary Heart Disease

  • 1. The First hospital of Hebei Medical University, Shijiazhuang, China

  • 2. Hebei Medical University, Shijiazhuang, China

Article metrics

View details

335

Views

The final, formatted version of the article will be published soon.

Abstract

Objective: To investigate the association between sarcopenia and ventricular remodelling after coronary artery bypass grafting (CABG) in elderly patients with coronary heart disease (CHD). Methods: A total of 135 elderly patients with CHD admitted to hospital between February 2021 and May 2023 were prospectively selected. According to whether ventricular remodelling occurred during the follow-up period, patients were divided into an occurrence group and a non-occurrence group. Results: The incidence of ventricular remodelling after CABG in elderly patients with CHD was 23.70% (32/135). Significant differences between the two groups were observed in smoking history, diabetes history, prevalence of sarcopenia, degree of preoperative coronary stenosis, levels of lipoprotein (a) ([Lp(a)]), uric acid (UA), protease-activated receptor 2 (PAR2), monocyte-to-HDL ratio (MHR), and suspended red blood cell input (P < 0.05). Multivariable logistic regression analysis identified smoking history (odds ratio [OR] = 2.186, 95% confidence interval [CI] 1.34–3.57), diabetes history (OR = 2.171, 95% CI 1.32–3.58), sarcopenia (OR = 2.230, 95% CI 1.37–3.62), a high degree of preoperative coronary stenosis (OR = 2.223, 95% CI 1.36–3.64), elevated Lp(a) (OR = 2.143, 95% CI 1.32–3.49), elevated UA (OR = 2.164, 95% CI 1.31–3.58), elevated PAR2 (OR = 2.192, 95% CI 1.32–3.64), and elevated MHR (OR = 2.201, 95% CI 1.32–3.68) as independent risk factors for ventricular remodelling after CABG in the study population. Analysis showed that sarcopenia predicted ventricular remodelling with a sensitivity of 90.0%, specificity of 47.0%, and an area under the curve of 0.772 (95% CI 0.68–0.86, P < 0.0001). Conclusion: Sarcopenia is a risk factor affecting ventricular remodelling after CABG in elderly patients and shows strong predictive efficacy in this population.

Summary

Keywords

coronary heart disease, elderly patients, coronary artery bypass grafting, Left ventricular remodelling, Sarcopenia

Received

27 May 2025

Accepted

21 November 2025

Copyright

© 2025 Li, Ma, Li, Su and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Zhenyu Su; Xugang Wang

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Share article

Article metrics